Final Glance: Biotechnology companies
News | 10 July 2012
Final Glance: Biotechnology companies.
Click on the link to read the full article at CBS News
(This link will open in a new window)
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
